logo
  

Aridis Acquires Rights For Development And Commercialization Of Suvratoxumab

Aridis Pharmaceuticals Inc. (ARDS) said that it has acquired global exclusive rights from AstraZeneca (AZN,AZN.L) for development and commercialization of the late stage monoclonal antibody candidate suvratoxumab for all indications.

AstraZeneca retains rights of first negotiation for future licensing.

Aridis said it will make an upfront payment to AstraZeneca of $11 million in cash and Aridis common stock. AstraZeneca will also receive up to a further $115 million on achievement of certain development and sales-related milestones, in addition to tiered royalties on net sales.

Suvratoxumab monoclonal antibody (mAb) for prevention of pneumonia has been licensed from AstraZeneca. Suvratoxumab extends Aridis' pneumonia franchise by complementing the existing AR-301 Phase 3 pneumonia treatment program.

Suvratoxumab and AR-301 are complementary products. Suvratoxumab's focus on preventive treatment of S. aureus pneumonia complements Aridis' AR-301 Phase 3 mAb program which is being developed as a therapeutic treatment of S. aureus pneumonia.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Green Field Farms Dairy has recalled its Whole Chocolate Milk product as a laboratory analysis indicated that the product was not effectively pasteurized, the U.S. Food and Drug Administration announced. The recall involves 1,242 units of the Whole Chocolate Milk with an expiration date of September 29, 2021. General Motors will start replacing defective battery modules in Chevrolet Bolt EVs and EUVs with new modules. The replacement battery modules will be shipped to dealers as soon as mid-October, the automaker said in a statement. CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing.
Follow RTT